Clinical trial · Observational
Volume 3D_US Kidney
Measurement of Kidney Volume and Renal Tumor Volume Using 3D-Ultrasound Imaging
NCT03841149CI-TRIAL-00107267VolUS3DcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to measure the volume of the kidney and tumors using 3D-US acquisition and to correlate these measurements to contrast-enhanced CT or MRI.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Kidney Diseases | — | UNRESOLVED | — |
| Renal Tumor | Kidney Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ultrasound Imaging | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- VolUS3D patients
- description
- Patients with renal tumour
- interventionNames
- Other: Ultrasound Imaging
Primary outcomes (1)
- measure
- 3D-US volume measurements
- timeFrame
- 1 month
- description
- Kidney and renal tumor
Secondary outcomes (3)
- measure
- 2D-US volume measurements
- timeFrame
- 1 month
- description
- Kidney and renal tumor
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patient (age 18) * Absence of participant's opposition * No contra-indication to contrast-enhanced CT AND MRI (a single contrast-enhanced imaging modality is sufficient) * Affiliated to Social Security Exclusion Criteria: \- Contra-indication to both contrast-enhanced CT AND MRI
References
Publications (0)
Data not yet available
No reference posted for this study.